Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma
Patients undergoing definitive surgery or ablative techniques for nonmetastatic kidney cancer have varying degrees of risk of recurrent disease post procedure. The ultimate goal of “adjuvant therapy” is to reduce the incidence of recurrent disease, and to cure more patients. We summarize the current...
Saved in:
| Main Authors: | Naomi B. Haas, Jeffrey Shevach, Ian D. Davis, Tim Eisen, Marine Gross-Gupil, Anil Kapoor, Viraj A. Master, Christopher W. Ryan, Manuela Schimdinger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-11-01
|
| Series: | Société Internationale d’Urologie Journal |
| Subjects: | |
| Online Access: | https://siuj.org/index.php/siuj/article/download/222/164 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress of immune checkpoint inhibitors in the treatment of acral melanoma
by: QIAN Jiajia, RUAN Cong, LIU Jiyong, XU Rui
Published: (2025-07-01) -
Advances and future perspectives of neoadjuvant immunotherapy in colorectal cancer
by: ZHANG Yuyang, LIU Qian
Published: (2025-07-01) -
Comparison of Adjuvant and Salvage Therapy with Immune Checkpoint Inhibitors in Head and Neck Mucosal Melanoma Treated with Proton Beam Therapy: A Retrospective Cohort Study
by: Ken Horisaki, et al.
Published: (2025-07-01) -
Mutation-based, neoadjuvant treatment for advanced anaplastic thyroid carcinoma
by: Sabine Wächter, et al.
Published: (2025-08-01) -
Research trends of neoadjuvant therapy in lung cancer: a bibliometric analysis
by: Xiaoru Geng, et al.
Published: (2025-03-01)